Lanopepden (GSK 1322322) (Synonyms: GSK 1322322) |
Catalog No.GC32311 |
Lanopepden (GSK 1322322) (GSK 1322322) es un inhibidor peptÍdico de la deformilasa activo contra las cepas de Staphylococcus aureus con CIM de 1 y 1 mg/l para las cepas ATCC 29213 y ATCC 25923, respectivamente.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1152107-25-9
Sample solution is provided at 25 µL, 10mM.
Lanopepden (GSK 1322322) is a peptide deformylase inhibitor active against Staphylococcus aureus strains with MICs of 1 and 1 mg/L for ATCC 29213 and ATCC 25923 strain, respectively[1].
[1]. Peyrusson F, et al. Cellular pharmacokinetics and intracellular activity of the novel peptide deformylase inhibitor GSK1322322 against Staphylococcus aureus laboratory and clinical strains with various resistance phenotypes: studies with human THP-1 monocytes and J774 murine macrophages. Antimicrob Agents Chemother. 2015 Sep;59(9):5747-60.
Average Rating: 5
(Based on Reviews and 20 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *